Approach to skin conditions

History

  • Chief complaint
  • Discomfort, duration, rate of progression and location
  • Secondary history:
    • Systemic complaints
    • Mucosal involvement
    • Exposures to medicines, immunisations, chemicals, food, animals, insects, pets, plants, sunlight and sick contacts
    • Sexual history
  • PMHx and FHx

Examination

  • Inspect all skin, mucosal surfaces, nails, scalp, hair
  • Determine:
    • Distribution – Location of skin findings
      • Rashes on exposed skin should prompt inquiries about sun exposure, jewellery and topical agents
    • Pattern – Generalised body; face and scalp; trunk and axillae; groin and skin folds; and hands/feet/nails
    • Arrangement – Symmetry vs. asymmetry and configuration
    • Morphology
    • Extent
    • Evolutionary changes – Must identify the primary lesion

Distribution

  • Flexor: Atopic dermatitis, candidiasis, eczema, ichthyosis (rare genetic thickened scaly skin)
  • Sun exposure: Sunburn, photosensitive drug eruption, photosensitive dermatitis, SLE, viral exanthem, porphyria
  • Distal extremities: Viral exanthem, atopic or contact dermatitis, eczema, gonococcaemia
  • Front and back of chest: Pityriasis rosea, secondary syphilis, drug eruption, atopic or contact dermatitis, psoriasis
  • Clothing covered: Contact dermatitis, psoriasis, folliculitis
  • Acneiform: Acne, drug-induced acne, irritant dermatitides

Configuration

  • Annular – Ring
  • Arcuate – Curved
  • Circinate – Circular
  • Confluent – Blending together
  • Dermatomal
  • Discoid – Solid, round
  • Discrete – Separate
  • Grouped

The primary lesion

  • One that has not been altered by healing, treatment, complicating infection or scratching
  • Primary skin lesions are macules, papules, nodules, tumors, cysts, plaques, wheals, vesicles, bullae and pustules
  • Secondary skin lesions have been altered and are described as crusts, scales, fissures, erosions, ulcerations, excoriations, atrophy, scarring and lichenification
  • Papule <0.5cm (larger = nodule)
  • Vesicle < 5mm

DDx based on primary lesion morphology

  • Macule: Drug eruption, nevus, tattoo, rheumatic fever, secondary syphilis, viral exanthem, meningococcaemia (early), ecchymosis, vitiligo, tinea versicolor, cellulitis (early)
  • Papule: Acne, BCC, melanoma, nevus, warts, molluscum contagiosum, skin tags, atopic dermatitis, urticaria, eczema, folliculitis, insect bite, vasculitis, psoriasis, scabies, erythema multiforme, early varicella, gonococcaemia

DDx primary morphology

  • Plaque: Eczema, pityriasis rosea, tinea corporis, tinea versicolor, psoriasis, seborrhoeic dermatitis, urticaria, secondary syphilis, erythema multiforme
  • Nodule: BCC, SCC, metastatic carcinoma, melanoma, erythema nodosum, furuncle, lipoma, warts
  • Wheal: Urticaria, angioedema, insect bite, erythema multiforme
  • Pustule: Acne, gonococcaemia, folliculitis, hidradenitis suppurativa, herpes, impetigo, psoriasis, rosacea, pyoderma gangrenosum

DDx primary morphology

  • Vesicle: Herpes, impetigo, thermal burn, friction blister, toxic epidermal necrolysis, bullous pemphigoid, pemphigus vulgaris
  • Bulla: Bullous pemphigoid, thermal burn, friction burn, TEN/SJS, bullous impetigo, pemphigus vulgaris

DDx secondary morphology

  • Scales: Psoriasis, pityriasis rosea, eczema, secondary syphilis, tinea, tinea versicolor, xerosis, thermal burn
  • Crusts: Eczema, tinea, impetigo, contact dermatitis, insect bite
  • Erosions: Candidiasis, tinea, eczema, TEN, erythema multiforme, bullous pemphigoid, pemphigus vulgaris
  • Ulcers: Aphthous, chancroid, decubitus ulcer, thermal or friction injury, ischaemic, malignancy, primary syphilis chancre, bullous pemphigoid, pemphigus vulgaris, pyoderma gangrenosum, stasis ulcer

Target lesions

  • Three concentric colour zones
    • Dark central blister
    • Ring of paler pink and raised
    • Bright red outer ring
  • Can arise anywhere
  • Iris lesion is an early target lesion with only central dusky zone and red outer zone
  • Single component red plaques are also seen in erythema multiforme
  • Atypical target lesions have just two zones or indistinct border
    • In EM they are raised while in SJS/TEN they are flat
  • DDx
    • Erythema multiforme
    • Stevens-Johnson syndrome
    • TEN

Targetoid lesions

  • Targetoid lesions have concentric zones but are not due to erythema multiforme
  • DDx:
    • Melanocytic naevi
    • Targetoid lesions in urticaria: May show dermographism. Usually centre is normal skin.
    • Fixed drug eruption
    • Polymorphous light eruption (few hours after light exposure)
    • Erythema annulare centrifugum
    • Subacute cutaneous lupus erythematosus (often following sun exposure on back/chest)
    • Polymorphic eruption of pregnancy (last 3 months with pink papules over stretch marks – very itchy)
    • Immunobullous disorders (paraneoplastic pemphigus, bullous pemphigoid)
    • Vasculitis (Kawasakis)

Drug eruptions

  • Exanthematous
    • Morbilliform, scarlatiniform or confluent erythematous patches
    • Mostly seen with EBV, HIV, leukaemia and concomitant allopurinol use
  • DRESS
    • Drug reactions with eosinophilia and systemic symptoms
    • Aka drug hypersensitivity syndrome with fever, malaise, lymphadenopathy and skin eruptions
    • Usually 2-6 weeks after initiation
    • Severe reaction seen with phenytoin, carbamazepine, lamotrigine, phenobarbitone, allopurinol and sulfas
    • Associated with exfoliative dermatitis, hepatitis, pneumonitis and renal impairment
  • Drug-induced urticaria/angioedema
    • Angioedema and wheal/flare within 3 weeks of exposure
    • May be IgE mediated type I hypersensitivity (esp. antibiotics) or mast-cell degranulation not by IgE-mediated process (e.g. opioids, vancomycin red man)
  • Fixed-drug eruption
    • Solitary or multiple oval plaques +- central blisters with dark postinflammatory pigmentation
    • Reoccur at same sites with re-exposure
    • Typically lips, tongue, genitalia, face and acral regions
    • NSAID’s, bactrim, doxycycline, penicillins, quinolones, barbiturates, paracetamol and antimalarials
  • Drug-induced photosensitivity
    • Immunological (e.g. photoallergic) – UV-A converts drug into immunologically active compound leading to eczema. Seen with topical soaps, fragrances, chlorpromazine, sulfas and NSAID’s + quinine
    • Toxicological (e.g. phototoxic) – Drug absorbs UV-A and releases energy causing inflammation. Presents as exaggerated sunburn with blistering. Seen with NSAID’s, doxycycline, ciprofloxacin, amiodarone and chlorpromazine
  • Drug-induced pigmentation
  • Cutaneous small vessel vasculitis (aka serum sickness)
    • Single organ vasculitis
    • Hydralazine, propylthiouracil most often
    • Antibiotics and sulfas also seen
    • Palpable purpura, petechiae, fever, arthralgias, lymphadenopathy, low serum complement levels and raised ESR.
    • Usually 7-10 days after exposure
  • Exfoliative dermatitis/erythroderma
    • Chronic erythema and scale >90% BSA
    • Seen with allopurinol, penicillins, phenobarbitone
  • SJS/TEN
  • Anaphylaxis
  • Erythema multiforme
    • Typically infection-driven but has been seen with anticonvulsants, penicillins

Hypersensitivity reactions

  • Type I – IgE mediated
  • Type II – Cytotoxic. Antibody-dependent. Complement. E.g. Goodpastures, Myaesthenia gravis, autoimmune haemolytic anaemia
  • Type III – Immune complex. Serum sickness, RA
  • Type IV – Delayed-type. Cell-mediated. Contact dermatitis, Mantoux test

Last Updated on October 13, 2021 by Andrew Crofton